E

Enzymatica AB (publ)
STO:ENZY

Watchlist Manager
Enzymatica AB (publ)
STO:ENZY
Watchlist
Price: 3.1 SEK 6.16%
Market Cap: 752.5m SEK

Intrinsic Value

ENZY's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ENZY stock under the Base Case scenario is 1.89 SEK. Compared to the current market price of 3.1 SEK, Enzymatica AB (publ) is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ENZY Intrinsic Value
1.89 SEK
Overvaluation 39%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation History
Enzymatica AB (publ)

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ENZY
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ENZY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Enzymatica AB (publ)?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Enzymatica AB (publ)’s research
View All Researches
Enzymatica AB (publ)
STO:ENZY
SE
Pharmaceuticals
Market Cap
752.5m SEK
IPO
Jun 14, 2011
SE
Pharmaceuticals
Market Cap
752.5m SEK
IPO
Jun 14, 2011
Price
krfalse
EPS
krfalse
AI Assistant
AI Assistant
Ask me anything about Enzymatica AB (publ)
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Enzymatica AB (publ)

Current Assets 112m
Cash & Short-Term Investments 75.2m
Receivables 14.3m
Other Current Assets 22.4m
Non-Current Assets 83.2m
Long-Term Investments 2.6m
PP&E 14.4m
Intangibles 66.2m
Other Non-Current Assets 1k
Efficiency

Free Cash Flow Analysis
Enzymatica AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Enzymatica AB (publ)

Revenue
45.6m SEK
Cost of Revenue
-14.9m SEK
Gross Profit
30.7m SEK
Operating Expenses
-82.8m SEK
Operating Income
-52.1m SEK
Other Expenses
-1.1m SEK
Net Income
-53.2m SEK
Fundamental Scores

ENZY Profitability Score
Profitability Due Diligence

Enzymatica AB (publ)'s profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Enzymatica AB (publ)'s profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ENZY Solvency Score
Solvency Due Diligence

Enzymatica AB (publ)'s solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Enzymatica AB (publ)'s solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENZY Price Targets Summary
Enzymatica AB (publ)

Wall Street analysts forecast ENZY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENZY is 3.96 SEK with a low forecast of 2.71 SEK and a high forecast of 5.34 SEK.

Lowest
Price Target
2.71 SEK
13% Downside
Average
Price Target
3.96 SEK
28% Upside
Highest
Price Target
5.34 SEK
72% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Enzymatica AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for ENZY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ENZY Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ENZY stock?

The intrinsic value of one ENZY stock under the Base Case scenario is 1.89 SEK.

Is ENZY stock undervalued or overvalued?

Compared to the current market price of 3.1 SEK, Enzymatica AB (publ) is Overvalued by 39%.

Back to Top